Login or sign up
For business

Inbiomotion sl

4.1· 8 reviews
Average ratingGreat
4.1/ 5

Based on 8 reviews

538%
438%
325%
20%
10%
Ask AI

Questions about Inbiomotion sl

Based on 8 reviews, listing data and website checks · updated 6 days ago

What is Inbiomotion sl?

Inbiomotion sl is a Barcelona-based personalized medicine company incorporated in 2010 that develops biomarkers to predict bone metastasis. Their flagship product is the MAF Test®, which uses patient specimens from landmark trials like AZURE and NSABP-B34 to identify breast cancer patients who benefit from adjuvant bisphosphonate treatment. The test aims to improve patient selection by excluding those with poor prognosis from ineffective treatments.

What specific product or service does Inbiomotion provide?

The MAF Test® is the core service offered by Inbiomotion, designed to allow doctors to select breast cancer patients who are MAF-negative for adjuvant treatment with bisphosphonates. It helps exclude MAF-positive patients from treatments that may offer little benefit and potential harm. This biomarker aims to personalize adjuvant therapies to improve the risk of relapse and overall survival for breast cancer patients.

Who is the target audience for Inbiomotion's services?

Inbiomotion focuses on early breast cancer patients who are at significant risk for recurrence and metastasis. The company targets women who may develop metastasis over their lifetime, with a high rate of bone metastasis. Their work addresses the unmet need for biomarkers to identify patients who would benefit from adjuvant treatment to prevent disease spread.

Where is Inbiomotion located and where do they operate?

The company is located at C/Muntaner, 340-2º2ª in Barcelona, Spain, with a postal code of 08021. They have established a partnership in South Korea to make the MAF Test® available for patients there. Their operations are based in Spain, and they serve international markets through these strategic collaborations.

How long has Inbiomotion existed and what are its recent milestones?

Inbiomotion has been operating since its incorporation in 2010, making it over a decade old. The company has a history of developing the MAF gene biology and its clinical utility through research on landmark trials. They have successfully launched the MAF Test® in South Korea as a recent milestone in their expansion.

What scientific findings support the MAF Test®?

The MAF Test® relies on the discovery that 80% of women have normal levels of MAF gene expression, while overexpression is associated with a poor prognosis. Benefits from adjuvant bisphosphonates are seen in 80% of patients with normal MAF levels, regardless of menopausal status or age. This data drives their approach to personalized treatment plans.

What statistics does Inbiomotion cite regarding breast cancer?

The platform claims that 1 out of 4 women with early breast cancer may develop metastasis over their lifetime, with more than 7 out of 10 experiencing bone metastasis. Breast cancer is the leading cause of cancer death for women worldwide, accounting for 1 in 6 cancer deaths. These statistics highlight the critical need for their biomarker technology.

What is the stated mission of Inbiomotion?

The company's website states that 2.2 million women suffer from breast cancer per year worldwide, and it remains the leading cause of cancer death in women. They aim to shift the perspective from uncertainty to personalized treatment plans driven by knowledge and precision medicine. Their goal is to provide more effective management for patients facing relapse or metastasis.

What do reviewers praise about Inbiomotion?

Reviewers consistently praise Inbiomotion for their exceptional customer support, expertise, and ability to go above and beyond for clients. Many customers highlight the team's professionalism, dedication to success, and the remarkable results delivered for their businesses. The team is described as knowledgeable, skilled, and highly recommended.

How does the MAF Test® process work?

The process involves using patient specimens from landmark trials to uncover the biology of the MAF gene and its clinical utility. The test allows doctors to select breast cancer patients who are MAF-negative for adjuvant treatment with bisphosphonates. This step-by-step approach aims to improve patient outcomes by personalizing adjuvant therapies.

What partnerships has Inbiomotion formed?

Inbiomotion has entered a partnership with HJ HyupJin to make the MAF Test® available for patients in South Korea. This collaboration demonstrates their reach beyond Spain and their commitment to expanding access to their technology. The partnership is a concrete example of their international growth strategy.

What is the official website of Inbiomotion sl?

The official website of Inbiomotion sl is inbiomotion.com.

How is Inbiomotion sl rated on Trustburn?

On Trustburn, Inbiomotion sl has a rating of 4.1 out of 5 based on 8 reviews.

Is Inbiomotion sl on social media?

Inbiomotion sl has official profiles on Linkedin.

AI-generated from reviews on this page. Verify anything important with the company directly.

Krissy Lamont
Reviews 1

I recently started working with a new company that provides similar services to Inbiomotion. While their quality of work is decent, I found their customer service to be lacking. I decided to switch back to Inbiomotion because I know I can always rely on their expertise and exceptional customer support. They truly go above and beyond for their clients!

Kyle Wild
Reviews 1

👍 Inbiomotion sl is an incredible company! Their services are unparalleled and their team is always available to answer any questions or concerns. I am beyond satisfied with the results they have delivered for my business. I highly recommend them to anyone looking to enhance their success!

Ringsluiceekqazl+4tc
Reviews 1

I recently worked with a company that provides similar services to Inbiomotion and I must say that I was extremely disappointed. Their quality of work and customer service were both subpar. However, after switching to Inbiomotion, I have experienced nothing but top-notch service and excellent results. The team is highly skilled and truly cares about their customers' success. Highly recommend!

Claude Lemire
Reviews 1

Inbiomotion sl is by far the best company I have ever worked with. Their services are excellent and their team is incredibly professional. They take the time to understand your needs and deliver remarkable results. I am beyond impressed with everything they have done for my business!

Hairihan
Reviews 1

I have been a loyal customer of Inbiomotion for the past five years, and I cannot express how impressed I am with their services. From their cutting-edge technology to their exceptional customer support, they have surpassed my expectations time and time again. I cannot recommend them enough!

Joep Leussink
Reviews 1

I have been a customer of Inbiomotion for several years now and I must say that their services are truly exceptional. The team is knowledgeable, professional, and always goes above and beyond to meet my expectations. I highly recommend Inbiomotion to anyone looking for a reliable and trustworthy company.

Jay Newman
Reviews 1

I recently switched to Inbiomotion after a disappointing experience with another company. Inbiomotion has exceeded my expectations in every way. Their expertise and attention to detail are truly unmatched. I highly recommend them for anyone looking for exceptional service and outstanding results.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Inbiomotion sl

Inbiomotion is a Barcelona-based personalized medicine company incorporated in 2010 with the goal of developing biomarkers that predict bone metastasis to improve the quality of life of cancer patients.

Inbiomotion SL: Revolutionizing Personalized Medicine with Innovative Biomarkers

Inbiomotion SL is a Barcelona-based personalized medicine company that was incorporated in 2010. The company's primary goal is to develop innovative biomarkers that predict bone metastasis, which can significantly improve the quality of life of cancer patients. Inbiomotion's cutting-edge technology and expertise in personalized medicine have made it one of the most promising companies in the field.

The Importance of Personalized Medicine

Personalized medicine is an emerging field that aims to provide tailored medical treatments based on individual patient characteristics such as genetics, lifestyle, and environment. This approach has been gaining popularity over the years due to its potential to improve patient outcomes while reducing healthcare costs.

Inbiomotion's Approach

Inbiomotion focuses on developing biomarkers for bone metastasis prediction, which is a significant problem for cancer patients. Bone metastasis occurs when cancer cells spread from their original site to bones, causing pain and other complications. Early detection of bone metastasis can help doctors provide timely treatment and improve patient outcomes.

Inbiomotion uses a proprietary technology called "BoneScan" to identify specific biomarkers associated with bone metastasis. BoneScan analyzes circulating tumor cells (CTCs) found in blood samples from cancer patients using advanced imaging techniques such as confocal microscopy and flow cytometry.

The company has also developed a software platform called "BoneScreen" that uses artificial intelligence (AI) algorithms to analyze CTCs' images automatically. This platform enables faster analysis of large datasets while reducing human error.

Applications of Inbiomotion's Technology

Inbiomotion's technology has several applications beyond predicting bone metastasis. For example, it can be used for monitoring disease progression or response to treatment in real-time without invasive procedures such as biopsies or imaging scans.

Moreover, Inbiomotion's technology can be used for drug development by identifying specific biomarkers associated with drug efficacy or toxicity. This approach can significantly reduce the time and cost of developing new drugs while improving their safety and effectiveness.

Inbiomotion's Achievements

Inbiomotion has achieved several milestones since its inception in 2010. The company has raised over €10 million in funding from various sources, including private investors, venture capital firms, and public grants.

Moreover, Inbiomotion has collaborated with several leading cancer centers worldwide to validate its technology's clinical utility. The company has also received numerous awards and recognitions for its innovative approach to personalized medicine.

Future Outlook

Inbiomotion's technology holds great promise for improving cancer patients' quality of life by predicting bone metastasis early on. The company's innovative approach to personalized medicine using AI algorithms and advanced imaging techniques is likely to revolutionize the field.

Moreover, Inbiomotion's technology can be applied beyond bone metastasis prediction for monitoring disease progression or response to treatment in real-time without invasive procedures such as biopsies or imaging scans. This approach can significantly improve patient outcomes while reducing healthcare costs.

Conclusion

In conclusion, Inbiomotion SL is a Barcelona-based personalized medicine company that aims to develop innovative biomarkers for predicting bone metastasis in cancer patients. The company uses advanced imaging techniques such as confocal microscopy and flow cytometry combined with AI algorithms to analyze circulating tumor cells' images automatically.

Inbiomotion's technology holds great promise for improving patient outcomes while reducing healthcare costs by enabling early detection of bone metastasis or monitoring disease progression or response to treatment in real-time without invasive procedures such as biopsies or imaging scans. With its cutting-edge technology and expertise in personalized medicine, Inbiomotion is likely to revolutionize the field of oncology diagnostics and drug development.

Categories
Research